Home      Tickers | SPY | NQ100 | DOW | Global | ETFs | Sector ETFs | 3x ETFs | ETF Movers | Stock Movers | Trading Alerts
     ^  MYL:  Intraday  Hourly  Forecast  Similar  Waves  GapOpen  Research  Timing  Gains  Losses  Strategies  Practice
     Wed. Mar. 13, 2019

Trading Signals: MYL Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Mon. Nov. 16, 2020)

(Mylan NV)

MYL latest price $27.4700 (0.37%) ($27.1800 - $27.6300) on Wed. Mar. 13, 2019.


Trend Analysis and Forecast
 
Average Daily Percentage Swing  2.96% (three month average)
RSI   33
Latest Price   $27.4700(0.37%)
Stocks Behave Similarly  Similar Stock List
Daily Trend  MYL advances 0.3% a day on average for past five trading days.
Weekly Trend  MYL declines -4.7% a week on average for past two weeks.
Market Behavior  Broad based rally for large cap. Normal for small cap.
Correlated ETFs  Broad market will support MYL advance at 0% a week (0% probability)
  IWN(58%)    IWC(56%)    IWM(56%)    IWO(54%)    PAVE(54%)  
Factors Impacting MYL price  MYL will decline at least -1.48% in a week (0% probabilities).
  TLT(-26%)    UUP(-25%)    IGOV(-16%)    VXX(-15%)    VIXM(-12%)  
Explanation   The rally is not sustainable and not supported by the broad market.
 
 
Relative Volatility   (options are extremely cheap)
 
Market Trend Strength  -1.48% (StdDev 2.96%)
Hourly BBV   0 ()
Intraday Trend   0%
  
 

  


1 - 5 Day Possible Target  $13.15(-52.13%)
Resistance Level  $28.89
5 Day Moving Average  $27.09(1.4%)
10 Day Moving Average  $27.18(1.07%)
20 Day Moving Average  $28.89(-4.92%)
To recent high  -14.4%
To recent low  5.6%
Market Cap  $14.201b
 
 
 
Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.

$. MYL price fluctuates within 7.58% (three month std-dev: 2.96%) daily (68% of days).

getNextHourMoveProbability failed